An open-label prospective trial designed to evaluate the safety and efficacy of bronchoscopic lung volume reduction (BLVR) by autologous blood injection in emphysematous lung diseases
Not Applicable
Recruiting
- Conditions
- Emphysematous lung disease
- Registration Number
- JPRN-UMIN000001310
- Lead Sponsor
- DMC COPD Research Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) Evidence of active infection. 2) Evidence of systemic diseases or neoplasia expected to compromise survival during 5-yr period. 3) Any disease or condition that interferes with completion of initial or follow-up assessments. 4) Patients who are judged by the principal or other investigators to be not eligible for enrollment in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse events/ Changes of symptomatic relief assessed by dyspnea scale/ Changes of pulmonary physiological parameters
- Secondary Outcome Measures
Name Time Method